Novartis, Adamis keep swinging at EpiPen with Symjepi pediatric doseAllbiopro2018-09-29T12:44:07+09:009월 29th, 2018|
Novartis looks ahead to China with Kymriah manufacturing pactAllbiopro2018-09-29T12:43:40+09:009월 29th, 2018|
Pfizer’s once-failed Vizimpro rebounds with targeted lung cancer approvalAllbiopro2018-09-29T12:43:11+09:009월 29th, 2018|
Johnson & Johnson CAR-T partner GenScript yo-yos on fake data allegationsAllbiopro2018-09-30T17:15:53+09:009월 29th, 2018|
EuroBiotech Report—Nightstar data, Minoryx B round, Entera and NovartisAllbiopro2018-09-29T12:41:46+09:009월 29th, 2018|
Hey Praesto: Purolite opens Protein A plant, opens up resin marketAllbiopro2018-09-29T12:41:17+09:009월 29th, 2018|
Emergent extends ABEC disposable deal to equip Maryland plantAllbiopro2018-09-29T12:40:49+09:009월 29th, 2018|
Understanding antibiotic resistance in patients with cystic fibrosisAllbiopro2018-09-29T12:40:20+09:009월 29th, 2018|
Productivity in Biopharma to Increase, CPhI Report PredictsAllbiopro2018-09-29T12:39:24+09:009월 29th, 2018|
Manufacturing License Granted to Alvotech for Biopharma FacilityAllbiopro2018-09-29T12:38:29+09:009월 29th, 2018|
Reaction Biology and Promega Partner on Bioassay ToolAllbiopro2018-09-29T12:38:00+09:009월 29th, 2018|
New Software Tools Enhance Real-Time Process Monitoring in LabsAllbiopro2018-09-29T12:37:32+09:009월 29th, 2018|
Pall and G-CON Collaborate on Scalable Turnkey Solutions for BioprocessingAllbiopro2018-09-29T12:37:05+09:009월 29th, 2018|
Just-Announced U.S. and Cuba Biopharma Venture Sees Fruit in Lung Cancer StudyAllbiopro2018-09-28T10:04:27+09:009월 28th, 2018|
